×
Sanuwave Health Inventory 2010-2024 | SNWVD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Sanuwave Health inventory from 2010 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
View More
Sanuwave Health Inventory 2010-2024 | SNWVD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Sanuwave Health inventory from 2010 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$198.7B
Stryker (SYK)
$134.5B
Boston Scientific (BSX)
$124.8B
Medtronic (MDT)
$116.2B
EssilorLuxottica (ESLOY)
$108B
Lonza Group Ag (LZAGY)
$46.2B
Haleon (HLN)
$44.6B
ResMed (RMD)
$37.6B
Koninklijke Philips (PHG)
$29.8B
Terumo (TRUMY)
$28.5B
Zimmer Biomet Holdings (ZBH)
$20.8B
Baxter (BAX)
$18.4B
Insulet (PODD)
$16.4B
Smith & Nephew SNATS (SNN)
$12.4B
Bio-Rad Laboratories (BIO)
$8.9B
Demant (WILYY)
$8.5B
BellRing Brands (BRBR)
$8.3B
Lantheus Holdings (LNTH)
$7.7B
ICU Medical (ICUI)
$4.3B
Haemonetics (HAE)
$3.9B
Prestige Consumer Healthcare (PBH)
$3.6B
TG Therapeutics (TGTX)
$3.6B
Perrigo (PRGO)
$3.4B
Envista Holdings (NVST)
$3.2B
Neogen (NEOG)
$3B
GN Store Nord (GNNDY)
$2.9B
QuidelOrtho (QDEL)
$2.6B
Agios Pharmaceuticals (AGIO)
$2.6B
Green Thumb Industries (GTBIF)
$2.3B
Curaleaf Holdings (CURLF)
$2.2B